The global Medical Hemostatic Agents market size was valued at USD 3601.4 million in 2022 and is forecast to a readjusted size of USD 5124.5 million by 2029 with a CAGR of 5.2% during review period.
Mechanical agents (also called passive substances) are generally thought to be the most effective for small amounts of bleeding and they create a barrier to stop blood flow and a surface that permits blood to clot more rapidly.
North America is the largest consumption region, with a more than 40% market share. Then Europe is the second largest consumption region with the market share of about 30%. J&J, Baxter, BD, Gelita, Pfizer, B Braun are the leaders of the global Medical Hemostatic Agents market, and they hold more than 65% market share. Medical Hemostatic Agents is widely used in Hospital, Surgical Centers and other field. The most proportion of Medical Hemostatic Agents is Hospital, and the sales proportion is about 65%. The classification of Medical Hemostatic Agents includes Gelation Hemostats, Combination Hemostats and Others Type. The proportion of Combination Hemostats and Gelation Hemostats in 2019 is more than 50%.
This report is a detailed and comprehensive analysis for global Medical Hemostatic Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Medical Hemostatic Agents market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Medical Hemostatic Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Medical Hemostatic Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Medical Hemostatic Agents market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Hemostatic Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Hemostatic Agents market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
J&J
Baxter
BD
Gelita
Pfizer
B Braun
CSL Behring
Ferrosan Medical Devices
Advance Medical Solution
Medtronic
Z-Medica
Marine Polymer
Equimedical
CryoLife
Gelation Hemostats
Combination Hemostats
Others
Hospitals
Surgical Centers
Others
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Strengths:
- Increasing demand for hemostatic agents due to rising surgical procedures and trauma cases, driving market growth.
- Technological advancements leading to the development of innovative products that enhance patient outcomes and reduce recovery times.
Weaknesses:
- High costs associated with advanced hemostatic agents may limit their accessibility in developing regions.
- Regulatory challenges and lengthy approval processes can delay product launches and market penetration.
Opportunities:
- Growing awareness and adoption of minimally invasive surgeries present opportunities for hemostatic agent manufacturers to expand their product offerings.
- Emerging markets are showing significant growth potential due to increased healthcare expenditure and rising surgical rates.
Threats:
- Intense competition from established players and new entrants may lead to price wars and decreased profit margins.
- Potential regulatory changes and market volatility can pose risks to the stability and growth of the hemostatic agents market.
Political:
- Government policies promoting healthcare infrastructure development and surgical advancements positively impact the demand for hemostatic agents.
- Stringent regulatory frameworks and approval processes for medical products can pose challenges to market entry.
Economic:
- Increasing healthcare spending in developed and emerging economies drives the adoption of advanced hemostatic agents.
- Economic uncertainties and budget constraints in certain regions may restrict market growth.
Social:
- Growing awareness about surgical safety and post-operative care increases the demand for effective hemostatic solutions.
- Aging populations worldwide contribute to a rise in surgeries, boosting the need for hemostatic agents.
Technological:
- Innovations in biomaterials and delivery systems enhance the effectiveness and applicability of hemostatic agents.
- Digital technologies, such as AI and data analytics, aid in the development of personalized hemostatic solutions.
Environmental:
- Sustainability concerns are pushing manufacturers to develop biodegradable and eco-friendly hemostatic agents.
- Environmental regulations regarding manufacturing processes can increase compliance costs for producers.
Legal:
- Intellectual property rights and patent protections encourage innovation but can create entry barriers for new players.
- Compliance with local and international medical device standards is critical for market participation.
Suppliers:
- Manufacturers of raw materials, such as polymers and biologics, play a critical role in producing hemostatic agents.
- Regulatory bodies that provide necessary approvals and guidelines for the development and distribution of hemostatic products.
Inputs:
- Research and development activities focused on creating innovative hemostatic solutions and improving existing products.
- Quality assurance processes that ensure the safety and efficacy of hemostatic agents before they reach the market.
Process:
- The production process involves the formulation, testing, and packaging of hemostatic agents, adhering to regulatory standards.
- Distribution channels include hospitals, surgical centers, and pharmacies, facilitating the delivery of hemostatic agents to end-users.
Outputs:
- A range of hemostatic products, including gels, powders, and sponges, designed for various surgical and trauma applications.
- Documentation of clinical trial results and regulatory approvals, providing evidence of product safety and efficacy.
Customers:
- Healthcare professionals, including surgeons and emergency responders, who require effective hemostatic solutions during procedures.
- Patients undergoing surgical procedures or experiencing trauma, who benefit from the timely application of hemostatic agents.
Threat of New Entrants:
- High barriers to entry due to strict regulatory requirements and the need for substantial capital investment in R&D.
- However, emerging technologies and growing demand in developing markets may encourage new players to enter the market.
Bargaining Power of Suppliers:
- Limited number of specialized suppliers for raw materials, such as bioengineered materials, increases their bargaining power.
- However, advancements in synthetic materials and diversification of supply chains may reduce supplier power over time.
Bargaining Power of Buyers:
- Large healthcare organizations and hospitals have significant bargaining power due to bulk purchasing of medical products.
- The increasing awareness and demand for better patient outcomes give healthcare professionals more influence in choosing hemostatic agents.
Threat of Substitutes:
- Alternatives such as cauterization, sutures, and traditional methods of hemostasis pose a moderate threat to hemostatic agents.
- However, innovative and more effective hemostatic solutions, like advanced biomaterials, reduce the likelihood of substitution.
Industry Rivalry:
- High competition among established companies with strong product portfolios and global reach drives innovation and price pressures.
- Continuous product development and improvements in efficacy keep the rivalry intense, though the market is expanding to accommodate new players.
Raw Materials:
- The availability and cost of raw materials, such as biopolymers and collagen, significantly influence the production of hemostatic agents.
- Suppliers of advanced materials, such as synthetic polymers and biologic substances, are key to the development of more effective products.
Technology:
- Advances in biotechnology and materials science drive innovation in hemostatic agents, enabling the development of more efficient and faster-acting products.
- Research into nanotechnology and biomaterials enhances the ability to create hemostatic agents with improved performance in various surgical scenarios.
Regulatory Environment:
- Stringent regulations regarding the safety and efficacy of hemostatic agents from bodies like the FDA and EMA shape product development and market entry.
- Compliance with international standards, including ISO certifications, is crucial for ensuring product quality and gaining market approval.
Supplier Relationships:
- Strong partnerships with research institutions and material suppliers enable hemostatic agent manufacturers to stay ahead in terms of product innovation and regulatory compliance.
- Long-term supplier relationships help mitigate supply chain disruptions and ensure consistent quality and availability of raw materials.
Manufacturing:
- Advanced manufacturing processes, such as automated production lines and sterile environments, ensure the consistent quality of hemostatic agents.
- The adoption of good manufacturing practices (GMP) and efficient production techniques helps reduce costs and improve scalability in the market.
R&D and Innovation:
- Ongoing research into new hemostatic technologies, such as bioactive agents and self-assembling materials, is critical for driving market growth and differentiation.
- Collaboration between manufacturers and research institutions accelerates the development of innovative products with enhanced performance and safety profiles.
Distribution:
- Efficient distribution networks, including partnerships with hospitals, surgical centers, and global medical suppliers, ensure wide availability of hemostatic agents.
- Growing e-commerce platforms and direct-to-hospital sales models are expanding the reach of hemostatic agents in both developed and emerging markets.
Quality Control:
- Rigorous quality control measures during manufacturing and testing phases are crucial for ensuring the safety and effectiveness of hemostatic agents.
- Adherence to international quality standards and certification processes strengthens the product’s reputation and market acceptance.
End Users:
- Healthcare providers, including hospitals, surgical centers, and trauma units, are the primary end users of hemostatic agents, requiring them for various surgical and emergency procedures.
- Increasing demand from outpatient surgeries and minimally invasive procedures drives the usage of hemostatic agents in diverse clinical settings.
Market Penetration:
- Established market players have strong brand recognition, enabling them to maintain dominant market positions and expand their customer base.
- New entrants are targeting emerging markets with cost-effective solutions, increasing competition and driving innovation in product offerings.
Customer Awareness:
- Surgeons and healthcare professionals are becoming more aware of the benefits of advanced hemostatic agents, contributing to increased demand.
- Patient education on faster recovery times and reduced complications from hemostatic agents is boosting their adoption in various medical settings.
Pricing and Reimbursement:
- Pricing strategies, including tiered pricing for different regions and healthcare systems, play a significant role in market penetration, especially in cost-sensitive markets.
- Reimbursement policies and healthcare insurance coverage in developed countries drive the adoption of advanced hemostatic products in hospitals and clinics.
Chapter 1, to describe Medical Hemostatic Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Hemostatic Agents, with price, sales, revenue and global market share of Medical Hemostatic Agents from 2018 to 2023.
Chapter 3, the Medical Hemostatic Agents competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Hemostatic Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Medical Hemostatic Agents market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Hemostatic Agents.
Chapter 14 and 15, to describe Medical Hemostatic Agents sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Medical Hemostatic Agents
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Medical Hemostatic Agents Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Gelation Hemostats
1.3.3 Combination Hemostats
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Medical Hemostatic Agents Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Surgical Centers
1.4.4 Others
1.5 Global Medical Hemostatic Agents Market Size & Forecast
1.5.1 Global Medical Hemostatic Agents Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Medical Hemostatic Agents Sales Quantity (2018-2029)
1.5.3 Global Medical Hemostatic Agents Average Price (2018-2029)
2 Manufacturers Profiles
2.1 J&J
2.1.1 J&J Details
2.1.2 J&J Major Business
2.1.3 J&J Medical Hemostatic Agents Product and Services
2.1.4 J&J Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 J&J Recent Developments/Updates
2.2 Baxter
2.2.1 Baxter Details
2.2.2 Baxter Major Business
2.2.3 Baxter Medical Hemostatic Agents Product and Services
2.2.4 Baxter Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Baxter Recent Developments/Updates
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business
2.3.3 BD Medical Hemostatic Agents Product and Services
2.3.4 BD Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BD Recent Developments/Updates
2.4 Gelita
2.4.1 Gelita Details
2.4.2 Gelita Major Business
2.4.3 Gelita Medical Hemostatic Agents Product and Services
2.4.4 Gelita Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Gelita Recent Developments/Updates
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Medical Hemostatic Agents Product and Services
2.5.4 Pfizer Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Pfizer Recent Developments/Updates
2.6 B Braun
2.6.1 B Braun Details
2.6.2 B Braun Major Business
2.6.3 B Braun Medical Hemostatic Agents Product and Services
2.6.4 B Braun Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 B Braun Recent Developments/Updates
2.7 CSL Behring
2.7.1 CSL Behring Details
2.7.2 CSL Behring Major Business
2.7.3 CSL Behring Medical Hemostatic Agents Product and Services
2.7.4 CSL Behring Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CSL Behring Recent Developments/Updates
2.8 Ferrosan Medical Devices
2.8.1 Ferrosan Medical Devices Details
2.8.2 Ferrosan Medical Devices Major Business
2.8.3 Ferrosan Medical Devices Medical Hemostatic Agents Product and Services
2.8.4 Ferrosan Medical Devices Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Ferrosan Medical Devices Recent Developments/Updates
2.9 Advance Medical Solution
2.9.1 Advance Medical Solution Details
2.9.2 Advance Medical Solution Major Business
2.9.3 Advance Medical Solution Medical Hemostatic Agents Product and Services
2.9.4 Advance Medical Solution Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Advance Medical Solution Recent Developments/Updates
2.10 Medtronic
2.10.1 Medtronic Details
2.10.2 Medtronic Major Business
2.10.3 Medtronic Medical Hemostatic Agents Product and Services
2.10.4 Medtronic Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Medtronic Recent Developments/Updates
2.11 Z-Medica
2.11.1 Z-Medica Details
2.11.2 Z-Medica Major Business
2.11.3 Z-Medica Medical Hemostatic Agents Product and Services
2.11.4 Z-Medica Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Z-Medica Recent Developments/Updates
2.12 Marine Polymer
2.12.1 Marine Polymer Details
2.12.2 Marine Polymer Major Business
2.12.3 Marine Polymer Medical Hemostatic Agents Product and Services
2.12.4 Marine Polymer Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Marine Polymer Recent Developments/Updates
2.13 Equimedical
2.13.1 Equimedical Details
2.13.2 Equimedical Major Business
2.13.3 Equimedical Medical Hemostatic Agents Product and Services
2.13.4 Equimedical Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Equimedical Recent Developments/Updates
2.14 CryoLife
2.14.1 CryoLife Details
2.14.2 CryoLife Major Business
2.14.3 CryoLife Medical Hemostatic Agents Product and Services
2.14.4 CryoLife Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 CryoLife Recent Developments/Updates
3 Competitive Environment: Medical Hemostatic Agents by Manufacturer
3.1 Global Medical Hemostatic Agents Sales Quantity by Manufacturer (2018-2023)
3.2 Global Medical Hemostatic Agents Revenue by Manufacturer (2018-2023)
3.3 Global Medical Hemostatic Agents Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Medical Hemostatic Agents by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Medical Hemostatic Agents Manufacturer Market Share in 2022
3.4.2 Top 6 Medical Hemostatic Agents Manufacturer Market Share in 2022
3.5 Medical Hemostatic Agents Market: Overall Company Footprint Analysis
3.5.1 Medical Hemostatic Agents Market: Region Footprint
3.5.2 Medical Hemostatic Agents Market: Company Product Type Footprint
3.5.3 Medical Hemostatic Agents Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Medical Hemostatic Agents Market Size by Region
4.1.1 Global Medical Hemostatic Agents Sales Quantity by Region (2018-2029)
4.1.2 Global Medical Hemostatic Agents Consumption Value by Region (2018-2029)
4.1.3 Global Medical Hemostatic Agents Average Price by Region (2018-2029)
4.2 North America Medical Hemostatic Agents Consumption Value (2018-2029)
4.3 Europe Medical Hemostatic Agents Consumption Value (2018-2029)
4.4 Asia-Pacific Medical Hemostatic Agents Consumption Value (2018-2029)
4.5 South America Medical Hemostatic Agents Consumption Value (2018-2029)
4.6 Middle East and Africa Medical Hemostatic Agents Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Medical Hemostatic Agents Sales Quantity by Type (2018-2029)
5.2 Global Medical Hemostatic Agents Consumption Value by Type (2018-2029)
5.3 Global Medical Hemostatic Agents Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Medical Hemostatic Agents Sales Quantity by Application (2018-2029)
6.2 Global Medical Hemostatic Agents Consumption Value by Application (2018-2029)
6.3 Global Medical Hemostatic Agents Average Price by Application (2018-2029)
7 North America
7.1 North America Medical Hemostatic Agents Sales Quantity by Type (2018-2029)
7.2 North America Medical Hemostatic Agents Sales Quantity by Application (2018-2029)
7.3 North America Medical Hemostatic Agents Market Size by Country
7.3.1 North America Medical Hemostatic Agents Sales Quantity by Country (2018-2029)
7.3.2 North America Medical Hemostatic Agents Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Medical Hemostatic Agents Sales Quantity by Type (2018-2029)
8.2 Europe Medical Hemostatic Agents Sales Quantity by Application (2018-2029)
8.3 Europe Medical Hemostatic Agents Market Size by Country
8.3.1 Europe Medical Hemostatic Agents Sales Quantity by Country (2018-2029)
8.3.2 Europe Medical Hemostatic Agents Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Medical Hemostatic Agents Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Medical Hemostatic Agents Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Medical Hemostatic Agents Market Size by Region
9.3.1 Asia-Pacific Medical Hemostatic Agents Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Medical Hemostatic Agents Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Medical Hemostatic Agents Sales Quantity by Type (2018-2029)
10.2 South America Medical Hemostatic Agents Sales Quantity by Application (2018-2029)
10.3 South America Medical Hemostatic Agents Market Size by Country
10.3.1 South America Medical Hemostatic Agents Sales Quantity by Country (2018-2029)
10.3.2 South America Medical Hemostatic Agents Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Medical Hemostatic Agents Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Medical Hemostatic Agents Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Medical Hemostatic Agents Market Size by Country
11.3.1 Middle East & Africa Medical Hemostatic Agents Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Medical Hemostatic Agents Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Medical Hemostatic Agents Market Drivers
12.2 Medical Hemostatic Agents Market Restraints
12.3 Medical Hemostatic Agents Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Medical Hemostatic Agents and Key Manufacturers
13.2 Manufacturing Costs Percentage of Medical Hemostatic Agents
13.3 Medical Hemostatic Agents Production Process
13.4 Medical Hemostatic Agents Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Medical Hemostatic Agents Typical Distributors
14.3 Medical Hemostatic Agents Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Medical Hemostatic Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Medical Hemostatic Agents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. J&J Basic Information, Manufacturing Base and Competitors
Table 4. J&J Major Business
Table 5. J&J Medical Hemostatic Agents Product and Services
Table 6. J&J Medical Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. J&J Recent Developments/Updates
Table 8. Baxter Basic Information, Manufacturing Base and Competitors
Table 9. Baxter Major Business
Table 10. Baxter Medical Hemostatic Agents Product and Services
Table 11. Baxter Medical Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Baxter Recent Developments/Updates
Table 13. BD Basic Information, Manufacturing Base and Competitors
Table 14. BD Major Business
Table 15. BD Medical Hemostatic Agents Product and Services
Table 16. BD Medical Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BD Recent Developments/Updates
Table 18. Gelita Basic Information, Manufacturing Base and Competitors
Table 19. Gelita Major Business
Table 20. Gelita Medical Hemostatic Agents Product and Services
Table 21. Gelita Medical Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Gelita Recent Developments/Updates
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Medical Hemostatic Agents Product and Services
Table 26. Pfizer Medical Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Pfizer Recent Developments/Updates
Table 28. B Braun Basic Information, Manufacturing Base and Competitors
Table 29. B Braun Major Business
Table 30. B Braun Medical Hemostatic Agents Product and Services
Table 31. B Braun Medical Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. B Braun Recent Developments/Updates
Table 33. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 34. CSL Behring Major Business
Table 35. CSL Behring Medical Hemostatic Agents Product and Services
Table 36. CSL Behring Medical Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. CSL Behring Recent Developments/Updates
Table 38. Ferrosan Medical Devices Basic Information, Manufacturing Base and Competitors
Table 39. Ferrosan Medical Devices Major Business
Table 40. Ferrosan Medical Devices Medical Hemostatic Agents Product and Services
Table 41. Ferrosan Medical Devices Medical Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Ferrosan Medical Devices Recent Developments/Updates
Table 43. Advance Medical Solution Basic Information, Manufacturing Base and Competitors
Table 44. Advance Medical Solution Major Business
Table 45. Advance Medical Solution Medical Hemostatic Agents Product and Services
Table 46. Advance Medical Solution Medical Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Advance Medical Solution Recent Developments/Updates
Table 48. Medtronic Basic Information, Manufacturing Base and Competitors
Table 49. Medtronic Major Business
Table 50. Medtronic Medical Hemostatic Agents Product and Services
Table 51. Medtronic Medical Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Medtronic Recent Developments/Updates
Table 53. Z-Medica Basic Information, Manufacturing Base and Competitors
Table 54. Z-Medica Major Business
Table 55. Z-Medica Medical Hemostatic Agents Product and Services
Table 56. Z-Medica Medical Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Z-Medica Recent Developments/Updates
Table 58. Marine Polymer Basic Information, Manufacturing Base and Competitors
Table 59. Marine Polymer Major Business
Table 60. Marine Polymer Medical Hemostatic Agents Product and Services
Table 61. Marine Polymer Medical Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Marine Polymer Recent Developments/Updates
Table 63. Equimedical Basic Information, Manufacturing Base and Competitors
Table 64. Equimedical Major Business
Table 65. Equimedical Medical Hemostatic Agents Product and Services
Table 66. Equimedical Medical Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Equimedical Recent Developments/Updates
Table 68. CryoLife Basic Information, Manufacturing Base and Competitors
Table 69. CryoLife Major Business
Table 70. CryoLife Medical Hemostatic Agents Product and Services
Table 71. CryoLife Medical Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. CryoLife Recent Developments/Updates
Table 73. Global Medical Hemostatic Agents Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Medical Hemostatic Agents Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Medical Hemostatic Agents Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Medical Hemostatic Agents, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Medical Hemostatic Agents Production Site of Key Manufacturer
Table 78. Medical Hemostatic Agents Market: Company Product Type Footprint
Table 79. Medical Hemostatic Agents Market: Company Product Application Footprint
Table 80. Medical Hemostatic Agents New Market Entrants and Barriers to Market Entry
Table 81. Medical Hemostatic Agents Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Medical Hemostatic Agents Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Medical Hemostatic Agents Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Medical Hemostatic Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Medical Hemostatic Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Medical Hemostatic Agents Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Medical Hemostatic Agents Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Medical Hemostatic Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Medical Hemostatic Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Medical Hemostatic Agents Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Medical Hemostatic Agents Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Medical Hemostatic Agents Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Medical Hemostatic Agents Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Medical Hemostatic Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Medical Hemostatic Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Medical Hemostatic Agents Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Medical Hemostatic Agents Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Medical Hemostatic Agents Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Medical Hemostatic Agents Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Medical Hemostatic Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Medical Hemostatic Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Medical Hemostatic Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Medical Hemostatic Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Medical Hemostatic Agents Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Medical Hemostatic Agents Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Medical Hemostatic Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Medical Hemostatic Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Medical Hemostatic Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Medical Hemostatic Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Medical Hemostatic Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Medical Hemostatic Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Medical Hemostatic Agents Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Medical Hemostatic Agents Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Medical Hemostatic Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Medical Hemostatic Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Medical Hemostatic Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Medical Hemostatic Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Medical Hemostatic Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Medical Hemostatic Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Medical Hemostatic Agents Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Medical Hemostatic Agents Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Medical Hemostatic Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Medical Hemostatic Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Medical Hemostatic Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Medical Hemostatic Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Medical Hemostatic Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Medical Hemostatic Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Medical Hemostatic Agents Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Medical Hemostatic Agents Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Medical Hemostatic Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Medical Hemostatic Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Medical Hemostatic Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Medical Hemostatic Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Medical Hemostatic Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Medical Hemostatic Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Medical Hemostatic Agents Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Medical Hemostatic Agents Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Medical Hemostatic Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Medical Hemostatic Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Medical Hemostatic Agents Raw Material
Table 141. Key Manufacturers of Medical Hemostatic Agents Raw Materials
Table 142. Medical Hemostatic Agents Typical Distributors
Table 143. Medical Hemostatic Agents Typical Customers
List of Figures
Figure 1. Medical Hemostatic Agents Picture
Figure 2. Global Medical Hemostatic Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Medical Hemostatic Agents Consumption Value Market Share by Type in 2022
Figure 4. Gelation Hemostats Examples
Figure 5. Combination Hemostats Examples
Figure 6. Others Examples
Figure 7. Global Medical Hemostatic Agents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Medical Hemostatic Agents Consumption Value Market Share by Application in 2022
Figure 9. Hospitals Examples
Figure 10. Surgical Centers Examples
Figure 11. Others Examples
Figure 12. Global Medical Hemostatic Agents Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Medical Hemostatic Agents Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Medical Hemostatic Agents Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Medical Hemostatic Agents Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Medical Hemostatic Agents Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Medical Hemostatic Agents Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Medical Hemostatic Agents by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Medical Hemostatic Agents Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Medical Hemostatic Agents Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Medical Hemostatic Agents Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Medical Hemostatic Agents Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Medical Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Medical Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Medical Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Medical Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Medical Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Medical Hemostatic Agents Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Medical Hemostatic Agents Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Medical Hemostatic Agents Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Medical Hemostatic Agents Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Medical Hemostatic Agents Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Medical Hemostatic Agents Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Medical Hemostatic Agents Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Medical Hemostatic Agents Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Medical Hemostatic Agents Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Medical Hemostatic Agents Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Medical Hemostatic Agents Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Medical Hemostatic Agents Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Medical Hemostatic Agents Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Medical Hemostatic Agents Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Medical Hemostatic Agents Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Medical Hemostatic Agents Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Medical Hemostatic Agents Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Medical Hemostatic Agents Consumption Value Market Share by Region (2018-2029)
Figure 54. China Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Medical Hemostatic Agents Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Medical Hemostatic Agents Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Medical Hemostatic Agents Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Medical Hemostatic Agents Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Medical Hemostatic Agents Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Medical Hemostatic Agents Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Medical Hemostatic Agents Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Medical Hemostatic Agents Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Medical Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Medical Hemostatic Agents Market Drivers
Figure 75. Medical Hemostatic Agents Market Restraints
Figure 76. Medical Hemostatic Agents Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Medical Hemostatic Agents in 2022
Figure 79. Manufacturing Process Analysis of Medical Hemostatic Agents
Figure 80. Medical Hemostatic Agents Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
